The Food and Drug Administration today published a proposed rule that would update requirements under the Mammography Quality Standards Act of 1992, which authorized FDA oversight of mammography facilities. According to the agency, the rule would expand the information that mammography facilities must provide to patients and health care professionals, modernize mammography quality standards and enhance facility oversight. For example, the rule would require that the facility report information on breast density in the report to the clinician and the patient’s summary letter to enable patients and their doctors to have a more informed discussion about the enhanced risks associated with dense breasts if appropriate. The agency will accept comments on the proposed rule for 90 days.

Related News Articles

Headline
The Measure Applications Partnership workgroups will meet virtually this week to discuss performance measures under consideration by the Centers for Medicare…
Headline
Learn how hospital and health system leaders such as Brian Miller, M.D., chief medical informatics officer and vice president of the Telehealth Institute at…
News
Teleflex has recalled a percutaneous thrombolytic device kit due to reports that a component could detach from the device and embolize. The Food and Drug…
Headline
The Centers for Medicare & Medicaid Services has extended the deadline for eligible hospitals to submit calendar year 2021 electronic clinical quality…
Chairperson's File
On this episode, I talk with Maureen Bisognano, a prominent authority on improving health care systems. Maureen served as Institute for Healthcare Improvement…
Perspective
Medicare Advantage plans provide essential health insurance coverage for approximately 22 million Americans, or about one-third of all Medicare beneficiaries…